116 related articles for article (PubMed ID: 20501488)
1. Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene.
Wurtz N; Briolant S; Gil M; Parquet V; Henry M; Baret E; Amalvict R; Almeras L; Rogier C; Pradines B
J Antimicrob Chemother; 2010 Jul; 65(7):1387-94. PubMed ID: 20501488
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.
Parquet V; Henry M; Wurtz N; Dormoi J; Briolant S; Gil M; Baret E; Amalvict R; Rogier C; Pradines B
Malar J; 2010 May; 9():139. PubMed ID: 20497586
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
[TBL] [Abstract][Full Text] [Related]
4. Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains.
Rason MA; Andrianantenaina HB; Ariey F; Raveloson A; Domarle O; Randrianarivelojosia M
Am J Trop Med Hyg; 2007 Jun; 76(6):1079-83. PubMed ID: 17556614
[TBL] [Abstract][Full Text] [Related]
5. Studies on antimalarial drug susceptibility in Colombia, in relation to Pfmdr1 and Pfcrt.
Restrepo-Pineda E; Arango E; Maestre A; Do Rosário VE; Cravo P
Parasitology; 2008 Apr; 135(5):547-53. PubMed ID: 18426617
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of the Plasmodium falciparum multidrug resistance and chloroquine resistance transporter genes and in vitro susceptibility to aminoquinolines in isolates from the Peruvian Amazon.
Huaman MC; Roncal N; Nakazawa S; Long TT; Gerena L; Garcia C; Solari L; Magill AJ; Kanbara H
Am J Trop Med Hyg; 2004 May; 70(5):461-6. PubMed ID: 15155976
[TBL] [Abstract][Full Text] [Related]
7. Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro.
Min TH; Khairul MF; Low JH; Che Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
Exp Parasitol; 2007 Apr; 115(4):387-92. PubMed ID: 17118354
[TBL] [Abstract][Full Text] [Related]
8. Pfmdr1 Asn1042Asp and Asp1246Tyr polymorphisms, thought to be associated with chloroquine resistance, are present in chloroquine-resistant and -sensitive Brazilian field isolates of Plasmodium falciparum.
Póvoa MM; Adagu IS; Oliveira SG; Machado RL; Miles MA; Warhurst DC
Exp Parasitol; 1998 Jan; 88(1):64-8. PubMed ID: 9501850
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs.
Pascual A; Henry M; Briolant S; Charras S; Baret E; Amalvict R; Huyghues des Etages E; Feraud M; Rogier C; Pradines B
Antimicrob Agents Chemother; 2011 May; 55(5):2472-4. PubMed ID: 21343466
[TBL] [Abstract][Full Text] [Related]
10. Short report: polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to amodiaquine and desethylamodiaquine.
Echeverry DF; Holmgren G; Murillo C; Higuita JC; Björkman A; Gil JP; Osorio L
Am J Trop Med Hyg; 2007 Dec; 77(6):1034-8. PubMed ID: 18165517
[TBL] [Abstract][Full Text] [Related]
11. Fluoxetine potentiates chloroquine and mefloquine effect on multidrug-resistant Plasmodium falciparum in vitro.
Khairul MF; Min TH; Low JH; Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
Jpn J Infect Dis; 2006 Oct; 59(5):329-31. PubMed ID: 17060702
[TBL] [Abstract][Full Text] [Related]
12. Reversal of chloroquine and mefloquine resistance in Plasmodium falciparum by the two monoindole alkaloids, icajine and isoretuline.
Frédérich M; Hayette MP; Tits M; De Mol P; Angenot L
Planta Med; 2001 Aug; 67(6):523-7. PubMed ID: 11509972
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of mefloquine-resistant mechanism of Plasmodium falciparum.
Nishiyama Y; Okuda Y; Kim HS; Huruta T; Kimura M; Wataya Y
Nucleic Acids Symp Ser (Oxf); 2004; (48):163-4. PubMed ID: 17150529
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province, China.
Yang Z; Zhang Z; Sun X; Wan W; Cui L; Zhang X; Zhong D; Yan G; Cui L
Trop Med Int Health; 2007 Sep; 12(9):1051-60. PubMed ID: 17875016
[TBL] [Abstract][Full Text] [Related]
15. Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya.
Holmgren G; Björkman A; Gil JP
Trop Med Int Health; 2006 Dec; 11(12):1808-12. PubMed ID: 17176345
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of candidate markers and in vitro susceptibility of Plasmodium falciparum isolates from Thai-Myanmar border in relation to clinical response to artesunate-mefloquine combination.
Phompradit P; Muhamad P; Chaijaroenkul W; Na-Bangchang K
Acta Trop; 2014 Nov; 139():77-83. PubMed ID: 25004442
[TBL] [Abstract][Full Text] [Related]
17. Influence of the Plasmodium falciparum P-glycoprotein homologue 1 (pfmdr1 gene product) on the antimalarial action of cyclosporin.
Gavigan CS; Shen M; Machado SG; Bell A
J Antimicrob Chemother; 2007 Feb; 59(2):197-203. PubMed ID: 17105736
[TBL] [Abstract][Full Text] [Related]
18. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.
Happi CT; Gbotosho GO; Folarin OA; Bolaji OM; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
Am J Trop Med Hyg; 2006 Jul; 75(1):155-61. PubMed ID: 16837724
[TBL] [Abstract][Full Text] [Related]
19. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.
Alker AP; Lim P; Sem R; Shah NK; Yi P; Bouth DM; Tsuyuoka R; Maguire JD; Fandeur T; Ariey F; Wongsrichanalai C; Meshnick SR
Am J Trop Med Hyg; 2007 Apr; 76(4):641-7. PubMed ID: 17426163
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria.
Parquet V; Briolant S; Torrentino-Madamet M; Henry M; Almeras L; Amalvict R; Baret E; Fusaï T; Rogier C; Pradines B
Antimicrob Agents Chemother; 2009 Jun; 53(6):2248-52. PubMed ID: 19307369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
